Increased Expression of Membrane-Type Matrix Metalloproteinase-1 Is Correlated With Poor Prognosis in Patients With Osteosarcoma

International Journal of Oncology - Greece
doi 10.3892/ijo.28.1.33
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Increased Six1 Expression Is Associated With Poor Prognosis in Patients With Osteosarcoma

Oncology Letters
Cancer ResearchOncology
2017English

Increased Expression of Pituitary Tumor-Transforming Gene (PTTG)-1 Is Correlated With Poor Prognosis in Glioma Patients

Oncology Reports
MedicineCancer ResearchOncology
2006English

High CCL5 Expression Is Associated With Osteosarcoma Metastasis and Poor Prognosis of Patients With Osteosarcoma

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Increased Expression of Matrix Metalloproteinase-9 in Patients With Temporal Lobe Epilepsy

Turkish Neurosurgery
SurgeryNeurology
2014English

Increased Expression of MMP-9 and IL-8 Are Correlated With Poor Prognosis of Bladder Cancer

BMC Urology
MedicineReproductive MedicineUrology
2012English

Trafficking of the Membrane Type-1 Matrix Metalloproteinase in Ischemia and Reperfusion: Relation to Interstitial Membrane Type-1 Matrix Metalloproteinase Activity

Circulation
Cardiovascular MedicinePhysiologyCardiology
2005English

Increased Expression of Lin28B Associates With Poor Prognosis in Patients With Oral Squamous Cell Carcinoma

PLoS ONE
Multidisciplinary
2013English

Increased Plasma Prothrombin Time Is Associated With Poor Prognosis in Patients With Paraquat Poisoning

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2018English

TLR4 Expression Correlated With PD-L1 Expression Indicates a Poor Prognosis in Patients With Peripheral T-Cell Lymphomas

Cancer Management and Research
Oncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy